NCT06043947Active, not recruiting
Survival Monitoring in Russian Cancer Registries
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
This study aims to establish a holistic framework for continuous cancer survival surveillance in Russian regions with high-quality population-based cancer registry data. The data from the population-based cancer registries of the Northwestern regions of Russia will be used to assess net and cause-specific survival trends.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100000 (estimated)
- First submitted
- 11 Sept 2023
- Start date
- 1 Aug 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- N.N. Petrov National Medical Research Center of Oncology
- Diseases
- Prostate cancer, Melanoma, Cervical cancer, Lung cancer, Colorectal cancer, Childhood cancers
- NCT number
- NCT06043947
What you commit to
- Study type: Observational
- Planned participants: 100000
- From 1 Aug 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Severe patient data missing from a record
Who the study is looking for
- Men and women of any age
- Data record meets IARC/IACR Tools for Cancer Registries requirements
Age in the registry: 0 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| N.N. Petrov Research Institute Of Oncology Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.